Position in ARGX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$503,872
-$3,622,669 QoQ
Shares Held
690
-85.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EVERGREEN CAPITAL MANAGEMENT LLC holds $21,167,675 across 26 Biotechnology names. ARGX ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,090 | $10,113,857 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,107 | $2,280,479 | |
| 3 | RPRX |
Royalty Pharma plc
|
19,335 | $927,499 | |
| 4 | NUVL |
Nuvalent, Inc.
|
8,952 | $917,132 | |
| 5 | PBYI |
Puma Biotechnology, Inc.
|
96,000 | $613,440 | |
| 6 | GMAB |
Genmab A/S
|
20,779 | $557,500 | |
| 7 | ARGX |
Argenx SE
This page
|
690 | $503,872 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
2,591 | $489,827 |
All Filings in ARGX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $503,872 | 690 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $4,126,541 | 4,907 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $654,953 | 888 | Shares | Other | 2025-10-28 | |
| 2025-06-30 | $320,258 | 581 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $346,241 | 585 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $384,375 | 625 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $245,020 | 452 | Shares | Other | 2024-11-14 | |
| 2024-03-31 | $203,946 | 518 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $204,671 | 538 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $289,078 | 588 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $203,049 | 521 | Shares | Other | 2023-08-14 | |
| 2022-12-31 | $204,189 | 539 | Shares | Other | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||